Nuvectis Pharma (NVCT) Non-Current Assets (2021)

Nuvectis Pharma (NVCT) reported Non-Current Assets of $824000.0 for Q4 2021.

Nuvectis Pharma (NVCT) Non-Current Assets (2021) Analysis & Trends

Nuvectis Pharma (NVCT) has 1 years of Non-Current Assets data on file, last reported at $824000.0 in Q4 2021.

  • For the quarter ending Q4 2021, Non-Current Assets changed N/A year-over-year to $824000.0; the trailing twelve-month figure through Sep 2022 stood at $824000.0 (changed N/A YoY), and the FY2021 full-year result was $824000.0, changed N/A from the prior year.
  • Non-Current Assets held at $824000.0 in Q4 2021.
  • In the past five years, Non-Current Assets ranged from a high of $824000.0 in Q4 2021 to a low of $824000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 21.65 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - 5.83 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 30.30 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 1.95 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 61.40 Bn 61.40 Bn - 289.41 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 285.82 Mn
10 Nuvectis Pharma 453.54 Mn 453.54 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2021 824,000.00